NICE Medicines Practice Guidelines 2 Patient Group Directions MPG2 2017

Jo Jenkins, Specialist Pharmacist (Patient Group Directions), Medicines Use and Safety (SPS)Source National Institute for Health and Care ExcellencePublished Last updated See all updates

NICE guidance providing good practice recommendations for individual people and organisations involved with the development, authorisation and use PGDs.

Non-SPS content · This content has not been generated nor formally reviewed by SPS

Non-SPS content is present where SPS believes that the content supports our end-users’ work, and is credible and trusted. Non-SPS content is posted in collaboration with the non-SPS author; however, it has not been generated nor formally reviewed by SPS

The guideline provides good practice recommendations for individual people and organisations involved with PGDs, with the aim of ensuring patients receive safe and appropriate care and timely access to medicines, in line with legislation.

It is written in the context of the NHS in England, including independent organisations or contractors who are commissioned to provide NHS services. It may also be applicable to individual people and organisations delivering non-NHS healthcare services, and to some of the devolved administrations.

Resources to support this guideline are also available. These include competency frameworks and a blank template. See links below.

 

Change history

  1. Page reviewed - no updates required
  1. Published